Literature DB >> 29705798

Disorders of Lipid Metabolism in Chronic Kidney Disease.

Mustafa C Bulbul1, Tuncay Dagel2, Baris Afsar3, Nuray N Ulusu4, Masanari Kuwabara5, Adrian Covic6, Mehmet Kanbay2.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death in chronic kidney disease (CKD). One of the most important pathophysiological mechanisms for CVD in patients with CKD is the widespread and possibly accelerated formation of atherosclerotic plaques due to hyperlipidemia, uremic toxins, inflammation, oxidative stress, and endothelial dysfunction. Recent studies showed that the level of oxidized low-density lipoprotein cholesterol increases, and that high--density lipoprotein cholesterol dysfunction occurs as kidney function declines and inflammation becomes more prevalent. In this review, we aimed to discuss the effect of kidney dysfunction, oxidative stress, and inflammation on lipid -profile.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Chronic kidney disease; Hyperlipidemia; Oxidized low-density lipoprotein

Mesh:

Year:  2018        PMID: 29705798     DOI: 10.1159/000488816

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  24 in total

Review 1.  The effect of chronic kidney disease on lipid metabolism.

Authors:  Neris Dincer; Tuncay Dagel; Baris Afsar; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2018-12-05       Impact factor: 2.370

2.  iTRAQ quantitative proteomic analysis differentially expressed proteins and signal pathways in henoch-schönlein purpura nephritis.

Authors:  Ran Gao; Xueli Niu; Lili Zhu; Ruiqun Qi; Liang He
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

3.  Cholesterol Metabolism in Chronic Kidney Disease: Physiology, Pathologic Mechanisms, and Treatment.

Authors:  Xiaoyue Pan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Targeting fatty acid metabolism for fibrotic disorders.

Authors:  Seonghwan Hwang; Ki Wung Chung
Journal:  Arch Pharm Res       Date:  2021-10-18       Impact factor: 4.946

Review 5.  The Roles of Fatty Acids and Apolipoproteins in the Kidneys.

Authors:  Xiaoyue Pan
Journal:  Metabolites       Date:  2022-05-20

6.  Longitudinal lipid trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.

Authors:  Ching-Wei Tsai; Han-Chun Huang; Hsiu-Yin Chiang; Chih-Wei Chung; Shih-Ni Chang; Pei-Lun Chu; Chin-Chi Kuo
Journal:  J Lipid Res       Date:  2019-01-14       Impact factor: 5.922

7.  Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.

Authors:  Yeonhee Lee; Sehoon Park; Soojin Lee; Yaerim Kim; Min Woo Kang; Semin Cho; Sanghyun Park; Kyungdo Han; Yong Chul Kim; Seoung Seok Han; Hajeong Lee; Jung Pyo Lee; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

8.  Global Proteome and Phosphoproteome Characterization of Sepsis-induced Kidney Injury.

Authors:  Yi-Han Lin; Maryann P Platt; Haiyan Fu; Yuan Gui; Yanlin Wang; Norberto Gonzalez-Juarbe; Dong Zhou; Yanbao Yu
Journal:  Mol Cell Proteomics       Date:  2020-09-22       Impact factor: 7.381

9.  Chronic treatment of curcumin improves hepatic lipid metabolism and alleviates the renal damage in adenine-induced chronic kidney disease in Sprague-Dawley rats.

Authors:  Hardik Ghelani; Valentina Razmovski-Naumovski; Dennis Chang; Srinivas Nammi
Journal:  BMC Nephrol       Date:  2019-11-21       Impact factor: 2.388

Review 10.  Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients.

Authors:  Anna Gluba-Brzozka; Beata Franczyk; Jacek Rysz
Journal:  Nutrients       Date:  2019-11-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.